Combretastatin A-4 prodrug: A potent inhibitor of malignant hemangioendothelioma cell proliferation
- 15 September 2000
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 87 (6) , 838-843
- https://doi.org/10.1002/1097-0215(20000915)87:6<838::aid-ijc13>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRIInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- A transformed murine myocardial vascular endothelial cell clone: characterization of cells in vitro and of tumours derived from the clone in situVirchows Archiv, 1995
- The interaction with tubulin of a series of stilbenes based on combretastatin A-4British Journal of Cancer, 1995
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- The JAM test A simple assay for DNA fragmentation and cell deathJournal of Immunological Methods, 1991
- Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulinBiochemistry, 1989
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989
- Cell biology of endothelial cellsHuman Pathology, 1987
- Isolation, Structure, and Synthesis of Combretastatins A-1 and B-1, Potent New Inhibitors of Microtubule Assembly, Derived from Combretum caffrumJournal of Natural Products, 1987